News | October 11, 2024
OneSource unveils new brand identity at CPHI Milan
Aims to achieve CDMO sales of US$ 400 million by 2028
Aims to achieve CDMO sales of US$ 400 million by 2028
We now rank 3rd in pharmaceutical production by volume and 14th by value
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
This is used to treat central diabetes insipidus and bedwetting
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
Enzalutamide Tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
Subscribe To Our Newsletter & Stay Updated
